Indeed, continuous exposure to Nutlin-3 promotes appearance of de novo p53 mutations associated with a multi-drug-resistant phenotype with an extremely high rate in several cancer cells, including neuroblastoma (Michaelis et al., 2011). The gene discussed is TP53; the disease is neuroblastoma.